CTBTO's radioxenon network for detecting nuclear tests is confounded by civilian medical-isotope production, which emits the same xenon fingerprint ~18,000 times a year

The Comprehensive Nuclear-Test-Ban Treaty's International Monitoring System (IMS) includes a radionuclide network that hunts for xenon-133 as a fingerprint of underground nuclear explosions — the gas seeps out even when a test is otherwise contained. According to the CTBTO, the same isotope is released in bulk by an entirely civilian activity: the production of molybdenum-99 (Mo-99), the parent isotope of the technetium-99m used in the majority of hospital cancer and cardiac scans. These medical-isotope emissions "look similar to those of a nuclear explosion," and the network registers "around 18,000 samples per year" carrying this civilian background.

The consequence is that the treaty organization must actively distinguish, and negotiate down, a signal produced by the world's cancer-imaging supply chain in order to keep its explosion-detection capability clean. Verification and medicine draw on the same fission-product chemistry, so the confounder is structural rather than incidental — it is simply what fission products do once released.

This is the sensor-based leg of the vault's verification cluster: it stands opposite the inspector-based regime described in claim-two-verification-regimes-sensor-vs-inspector-govern-the-same-fissile-material-lifecycle, and it is the concrete verification mechanism underlying open-source reconstructions like the radionuclide-plume reasoning in claim-burevestnik-reactor-emits-radionuclides-in-exhaust. The mitigation path the CTBTO's problem eventually opened onto — converting Mo-99 producers off weapons-usable uranium — is treated in claim-nnsa-converted-global-mo99-production-heu-to-leu-targets.